Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYDNEY 2: Thioctic Acid in Diabetic Polyneuropathy
NCT00328601Phase 3Completed
- Sponsor
- Meda
- Start
- Feb 2005
- Countries
- 2
01
Overview
A Phase 3 trial of alpha-lipoic acid in diabetic polyneuropathy (DPN), sponsored by Meda. Started Feb 2005; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00328601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328601.